Literature DB >> 11039593

Differential toxic effects of gentamicin on cultured renal epithelial cells (LLC-PK1) on application to the brush border membrane or the basolateral membrane.

K Kiyomiya1, N Matsushita, S Matsuo, M Kurebe.   

Abstract

Aminoglycoside antibiotics are generally accepted to accumulate in renal proximal tubule cells from the luminal surface and show toxic effects on the cells. The binding affinity and membrane permeability of aminoglycoside antibiotics are different at the brush border membrane (BBM) and the basolateral membrane (BLM) of proximal tubule cells. This study was performed, therefore, to investigate the differential effects of the aminoglycoside antibiotic gentamicin (GM) on cultured LLC-PK1 cells, a pig kidney proximal epithelial cell line, after addition to the BBM or the BLM side. LLC-PK1 cells were cultured on microporous membranes until forming confluent monolayers, and then GM was added to either the BBM or the BLM side. GM caused release of enzymes from the organelles, with a higher level of release observed following addition to the BBM side than that to the BLM side. Patterns of [3H]GM uptake by the cells differed in a manner dependent on whether it was added to the BBM or the BLM side. That is, the cellular uptake from the BBM side increased with incubation time, while that from the BLM side showed rapid saturation. These results suggested that aminoglycoside antibiotics show differential effects on cultured proximal epithelial cells and have differential patterns of cellular uptake when added to the BBM or the BLM side.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11039593     DOI: 10.1292/jvms.62.971

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  1 in total

1.  The utility of a rodent model in detecting pediatric drug-induced nephrotoxicity.

Authors:  Parvaneh Espandiari; Jun Zhang; Barry A Rosenzweig; Vishal S Vaidya; Jinchun Sun; Laura Schnackenberg; Eugene H Herman; Alan Knapton; Joseph V Bonventre; Richard D Beger; Karol L Thompson; Joseph Hanig
Journal:  Toxicol Sci       Date:  2007-07-17       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.